Latest News and Press Releases
Want to stay updated on the latest news?
-
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude Therapeutics” or the “Company”), a clinical-stage precision oncology company, today...
-
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed...
-
Marketbridge announced the appointment of Fiona McKenzie as President of its European operations.
-
Admiral Group Plc (“Admiral”) Notification under UKLR 6.4.9R(2) In compliance with UK Listing Rule 6.4.9R(2), Admiral announces that with effect from 15 April 2026, Fiona Muldoon, Independent...
-
MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation
-
PERTH, Australia, April 14, 2026 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQX: NSRPF) is pleased to announce that Mr. Rohan Willams, an experienced...
-
Brown & Brown names Eileen Akerson chief legal officer, effective immediately, after serving in the interim role since January 2026
-
SINGAPORE, April 14, 2026 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (“Antalpha” or the “Company”) (Nasdaq: ANTA), a leading fintech company specializing in providing financing,...
-
SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
-
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...